<DOC>
	<DOCNO>NCT01438086</DOCNO>
	<brief_summary>When patient heart attack , blockage occur coronary artery delivers oxygen heart muscle . The heart muscle may weaken , cause heart failure . The body naturally make protein call insulin-like growth factor-1 ( IGF-1 ) may protect heart muscle cell die may prevent heart failure lessen damage occur . IGF-1 also available drug call mecasermin . In study , heart attack patient give either dose mecasermin placebo ( inactive treatment ) coronary artery open stent . The purpose study evaluate safety therapy test therapy prevent lessen heart failure evaluate cardiac magnetic resonance imaging ( MRI ) take one day eight week heart attack .</brief_summary>
	<brief_title>Evaluation Safety Efficacy Using Insulin-like Growth Factor-1 Patients With Heart Attack</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>Age 18 75 Presents within 212 hour least 30 minute myocardial ischemic pain ECG evidence myocardial infarction Undergoing percutaneous coronary intervention ( PCI ) STelevation myocardial infarction Left ventricular ejection fraction PCI 40 % less TIMI flow grade 3 infarctrelated artery follow reperfusion stenting History prior myocardial infarction Prior history heart failure , leave ventricular dysfunction cardiomyopathy Active suspect neoplasia Known impair liver function Cardiogenic shock Estimated glomerular filtration rate &lt; 45 ml/min/1.73m2 History hypoglycaemia require hospitalisation History primary insulinlike growth factor1 deficiency growth hormone disorder Contraindication cardiac magnetic resonance imaging Pregnancy nursing mother Known allergy study drug inactive ingredient Treatment another investigational agent within 30 day enrolment Subjects unable unwilling comply followup requirement study Subjects unable provide write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Myocardial Infarction</keyword>
</DOC>